Gimhae, South Korea

Da Ryeon Son

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Stemlab Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Da Ryeon Son. Retrieved from https://idiyas.com/inventor/da-ryeon-son-uics0hfo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Da Ryeon Son: Innovator in Neural Stem Cell Research

Introduction

Da Ryeon Son is a prominent inventor based in Gimhae-si, South Korea. He has made significant contributions to the field of regenerative medicine, particularly in the area of neural stem cell research. His innovative approach has the potential to transform treatments for neurological damage diseases.

Latest Patents

Da Ryeon Son holds a patent for a groundbreaking method titled "Method for direct reprogramming of urine cells into neural stem cells using synthetic mRNA." This method involves inducing the reprogramming of neural stem cells from urine cells by introducing mRNAs of reprogramming factors Oct4, Sox2, Klf4, and Glis1. The patent also discloses a composition for the prevention or treatment of neurological damage diseases, utilizing the neural stem cells induced by this method as an active ingredient.

Career Highlights

Da Ryeon Son is currently associated with Stemlab Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new avenues for treating neurological conditions, showcasing his dedication to improving patient outcomes.

Collaborations

He collaborates with notable colleagues, including Seung Kwon You and Phil Jun Kang, who contribute to his research initiatives and help drive innovation in the field.

Conclusion

Da Ryeon Son's contributions to neural stem cell research exemplify the impact of innovative thinking in medicine. His patented methods and ongoing work at Stemlab Inc. highlight the potential for advancements in treating neurological diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…